Title: Pemirolast reduces cisplatin-induced kaolin intake in rats.
Journal: European journal of pharmacology20110701
Title: [Toxicity of topical ocular anti-allergic agents on human corneal epithelial cells in vitro].
Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology20100101
Title: Suppressive activity of pemirolast potassium, an antiallergic drug, on glomerulonephritis. Studies in glomerulonephritis model rats and in patients with chronic glomerulonephritis concurrently affected by allergic rhinitis.
Journal: Arzneimittel-Forschung20080101
Title: The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde20080101
Title: A late cutaneous response in actively sensitized rats: a new method for evaluating the efficacy of antiallergic drugs.
Journal: Journal of pharmacological sciences20060801
Title: Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer.
Journal: International journal of cancer20060515
Title: Tetrazole compounds: the effect of structure and pH on Caco-2 cell permeability.
Journal: Journal of pharmaceutical sciences20060401
Title: Peripheral interstitial keratitis: a novel manifestation of ocular mastocytosis.
Journal: Cornea20060401
Title: Comparison of antigen-induced leukotriene and histamine release from nasal scrapings in allergic rhinitis.
Journal: Rhinology20050901
Title: Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.
Journal: Biological & pharmaceutical bulletin20050301
Title: Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.
Journal: Neuropharmacology20040501
Title: A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics20040401
Title: Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
Journal: Japanese journal of ophthalmology20040101
Title: Preventive effect of an antiallergic drug, pemirolast potassium, on restenosis after stent placement: quantitative coronary angiography and intravascular ultrasound studies.
Journal: Journal of cardiology20030701
Title: A combined analysis of two studies assessing the ocular comfort of antiallergy ophthalmic agents.
Journal: Clinical therapeutics20030401
Title: Two mast cell stabilizers, pemirolast potassium 0.1% and nedocromil sodium 2%, in the treatment of seasonal allergic conjunctivitis: a comparative study.
Journal: Advances in therapy20030101
Title: Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics20021001
Title: Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology19971201
Title: A pilot study of pemirolast in patients with seasonal allergic rhinitis.
Journal: Annals of allergy19910201
Title: Kemp, J.P., et al., Pemirolast, a new oral nonbronchodilator drug for chronic asthma. Ann Allergy, 1992. 68(6): p. 488-91.
Title: Tatsushima, Y., et al., Pemirolast reduces cisplatin-induced kaolin intake in rats. Eur J Pharmacol, 2011. 661(1-3): p. 57-62.
Title: Itoh, Y., et al., Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats. Neuropharmacology, 2004. 46(6): p. 888-94.
Title: Abelson, M.B., et al., Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies. J Ocul Pharmacol Ther, 2002. 18(5): p. 475-88.
